194 related articles for article (PubMed ID: 30585550)
21. Mechanism Underlying
Yan X; Chen X; Xu X; Liu J; Fu C; Zhao D; Zhao W; Ma R; Sun L
J Agric Food Chem; 2020 Mar; 68(12):3742-3749. PubMed ID: 32129993
[TBL] [Abstract][Full Text] [Related]
22. Resveratrol Ameliorates Lipid Droplet Accumulation in Liver Through a SIRT1/ ATF6-Dependent Mechanism.
Zhou R; Yi L; Ye X; Zeng X; Liu K; Qin Y; Zhang Q; Mi M
Cell Physiol Biochem; 2018; 51(5):2397-2420. PubMed ID: 30537742
[TBL] [Abstract][Full Text] [Related]
23. Effects of Chamomilla recutita flavonoids on age-related liver sphingolipid turnover in rats.
Babenko NA; Shakhova EG
Exp Gerontol; 2006 Jan; 41(1):32-9. PubMed ID: 16183236
[TBL] [Abstract][Full Text] [Related]
24. Curcumin decreases oleic acid-induced lipid accumulation via AMPK phosphorylation in hepatocarcinoma cells.
Kang OH; Kim SB; Seo YS; Joung DK; Mun SH; Choi JG; Lee YM; Kang DG; Lee HS; Kwon DY
Eur Rev Med Pharmacol Sci; 2013 Oct; 17(19):2578-86. PubMed ID: 24142602
[TBL] [Abstract][Full Text] [Related]
25. A novel combined resveratrol/berberine phytochemotheraputic using the HePG2 cell line as a model for the treatment of hepatocarcinoma.
D'Arcy MS; Pike CVS; Coussons PJ
Cell Biol Int; 2021 Dec; 45(12):2499-2509. PubMed ID: 34460138
[TBL] [Abstract][Full Text] [Related]
26. A comparative assessment of antiproliferative properties of resveratrol and ethanol leaf extract of Anogeissus leiocarpus (DC) Guill and Perr against HepG2 hepatocarcinoma cells.
Olugbami JO; Damoiseaux R; France B; Onibiyo EM; Gbadegesin MA; Sharma S; Gimzewski JK; Odunola OA
BMC Complement Altern Med; 2017 Aug; 17(1):381. PubMed ID: 28768515
[TBL] [Abstract][Full Text] [Related]
27. Gene expression of sphingolipid metabolism pathways is altered in hidradenitis suppurativa.
Dany M; Elston D
J Am Acad Dermatol; 2017 Aug; 77(2):268-273.e6. PubMed ID: 28551069
[TBL] [Abstract][Full Text] [Related]
28. Sphingolipid metabolic changes during chiral C2-ceramides induced apoptosis in human leukemia cells.
Baek MY; Yoo HS; Nakaya K; Moon DC; Lee YM
Arch Pharm Res; 2001 Apr; 24(2):144-9. PubMed ID: 11339634
[TBL] [Abstract][Full Text] [Related]
29. Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis.
Le Stunff H; Galve-Roperh I; Peterson C; Milstien S; Spiegel S
J Cell Biol; 2002 Sep; 158(6):1039-49. PubMed ID: 12235122
[TBL] [Abstract][Full Text] [Related]
30. Resveratrol, a phytoestrogen found in red wine, down-regulates protein S expression in HepG2 cells.
Hiroto Y; Tadokoro K; Tsuda T; Nakazono E; Ohnaka K; Takayanagi R; Hamasaki N; Tsuda H
Thromb Res; 2011 Jan; 127(1):e1-7. PubMed ID: 20926118
[TBL] [Abstract][Full Text] [Related]
31. Long- and short-term effects of thyroxine on sphingolipid metabolism in rat liver.
Babenko NA
Med Sci Monit; 2005 May; 11(5):BR131-138. PubMed ID: 15874883
[TBL] [Abstract][Full Text] [Related]
32. Altered sphingolipid metabolism in human endometrial cancer.
Knapp P; Baranowski M; Knapp M; Zabielski P; Błachnio-Zabielska AU; Górski J
Prostaglandins Other Lipid Mediat; 2010 Jun; 92(1-4):62-6. PubMed ID: 20226264
[TBL] [Abstract][Full Text] [Related]
33. Grade-dependent changes in sphingolipid metabolism in clear cell renal cell carcinoma.
Młynarczyk G; Mikłosz A; Suchański J; Reza S; Romanowicz L; Sobolewski K; Chabowski A; Baranowski M
J Cell Biochem; 2022 Apr; 123(4):819-829. PubMed ID: 35187707
[TBL] [Abstract][Full Text] [Related]
34. Fermented Soymilk Alleviates Lipid Accumulation by Inhibition of SREBP-1 and Activation of NRF-2 in the Hepatocellular Steatosis Model.
Ahn SB; Wu WH; Lee JH; Jun DW; Kim J; Kim R; Lee TB; Jun JH
J Microbiol Biotechnol; 2018 Feb; 28(2):236-245. PubMed ID: 29169220
[TBL] [Abstract][Full Text] [Related]
35. Early fumonisin B1 toxicity in relation to disrupted sphingolipid metabolism in male BALB/c mice.
Tsunoda M; Sharma RP; Riley RT
J Biochem Mol Toxicol; 1998; 12(5):281-9. PubMed ID: 9664234
[TBL] [Abstract][Full Text] [Related]
36. Celecoxib-mediated activation of endoplasmic reticulum stress induces de novo ceramide biosynthesis and apoptosis in hepatoma HepG2 cells mobilization.
Maeng HJ; Song JH; Kim GT; Song YJ; Lee K; Kim JY; Park TS
BMB Rep; 2017 Mar; 50(3):144-149. PubMed ID: 28193314
[TBL] [Abstract][Full Text] [Related]
37. Sphingolipids: major regulators of lipid metabolism.
Worgall TS
Curr Opin Clin Nutr Metab Care; 2007 Mar; 10(2):149-55. PubMed ID: 17285002
[TBL] [Abstract][Full Text] [Related]
38. Functional lipidomics: Palmitic acid impairs hepatocellular carcinoma development by modulating membrane fluidity and glucose metabolism.
Lin L; Ding Y; Wang Y; Wang Z; Yin X; Yan G; Zhang L; Yang P; Shen H
Hepatology; 2017 Aug; 66(2):432-448. PubMed ID: 28073184
[TBL] [Abstract][Full Text] [Related]
39. Rosiglitazone ameliorates palmitic acid-induced cytotoxicity in TM4 Sertoli cells.
Ge X; Pan P; Jing J; Hu X; Chen L; Qiu X; Ma R; Jueraitetibaike K; Huang X; Yao B
Reprod Biol Endocrinol; 2018 Oct; 16(1):98. PubMed ID: 30333041
[TBL] [Abstract][Full Text] [Related]
40. Trans-resveratrol, a grapevine-derived polyphenol, blocks hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells.
De Lédinghen V; Monvoisin A; Neaud V; Krisa S; Payrastre B; Bedin C; Desmoulière A; Bioulac-Sage P; Rosenbaum J
Int J Oncol; 2001 Jul; 19(1):83-8. PubMed ID: 11408926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
